Lorenz C. Hofbauer, MD

Technische Universität Dresden
Dresden, Germany

Disclosure information not submitted.

Presentation(s):

• MON-771 - Improvements in Patient-Reported Outcomes With Eneboparatide in Chronic Hypoparathyroidism Over 1 Year: A Phase 3, Randomized, Placebo-Controlled and Open-Label Study Assessing the Efficacy and Safety of Eneboparatide (CALYPSO)

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT